Sam Brusco, Associate Editor08.26.22
Dentsply Sirona has appointed Simon Campion as its new president and CEO, replacing interim CEO John Groetelaars who has served since April. Campion will begin his role on September 12.
Campion was most recently executive VP and president of BD’s (Becton, Dickinson and Company) Medical segment. Prior to that he was president of the Interventional segment after BD’s purchase of C.R. Bard. He held several leadership roles there, including leading the Surgery business.
With Campion’s hiring, the Board requested full review of the company’s business and operations.
Campion told the press, “It’s an honor to join Dentsply Sirona and have the opportunity to lead this great team. During my career, I’ve developed a clear understanding of what it takes for a global healthcare company to succeed, and I am confident that with its strong foundation of industry-leading products and patient-driven innovation, Dentsply Sirona is well-positioned to capitalize on the market opportunities ahead and deliver long-term growth and value creation.”
Groetelaars added, “It has been a privilege to serve as Dentsply Sirona’s Interim CEO. Over the last several months, I’ve gained deep insight into Dentsply Sirona’s business, operations, and opportunities. Dentsply Sirona has a solid strategy in place, and I am eager to apply the perspectives I’ve gained as I continue to support the Company’s progress from the Board.”
Campion was most recently executive VP and president of BD’s (Becton, Dickinson and Company) Medical segment. Prior to that he was president of the Interventional segment after BD’s purchase of C.R. Bard. He held several leadership roles there, including leading the Surgery business.
With Campion’s hiring, the Board requested full review of the company’s business and operations.
Campion told the press, “It’s an honor to join Dentsply Sirona and have the opportunity to lead this great team. During my career, I’ve developed a clear understanding of what it takes for a global healthcare company to succeed, and I am confident that with its strong foundation of industry-leading products and patient-driven innovation, Dentsply Sirona is well-positioned to capitalize on the market opportunities ahead and deliver long-term growth and value creation.”
Groetelaars added, “It has been a privilege to serve as Dentsply Sirona’s Interim CEO. Over the last several months, I’ve gained deep insight into Dentsply Sirona’s business, operations, and opportunities. Dentsply Sirona has a solid strategy in place, and I am eager to apply the perspectives I’ve gained as I continue to support the Company’s progress from the Board.”